Literature DB >> 4565817

Single and combination nonhormonal chemotherapy in breast cancer.

S K Carter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4565817     DOI: 10.1002/1097-0142(197212)30:6<1543::aid-cncr2820300621>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  22 in total

1.  CAF versus CAF plus Medroxyprogesterone Acetate for Treatment of Liver Metastases of Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1995-04-30       Impact factor: 4.239

Review 2.  The concept of dose intensification in the treatment of neoplastic disease.

Authors:  U B Wandl; N Niederle
Journal:  Infection       Date:  1992       Impact factor: 3.553

3.  Medical oncology. Clinical experience over one year.

Authors:  J D McCracken
Journal:  West J Med       Date:  1975-06

4.  A phase II study of intensive-dose epirubicin/verapamil as induction therapy followed by intensive-dose ifosfamide for advanced breast cancer.

Authors:  T Langenbuch; K Mross; W Jonat; D K Hossfeld
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Phase II study of divided-dose vinblastine in advanced breast cancer patients.

Authors:  G Giaccone; M Bagatella; O Bertetto; M Donadio; A Calciati
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

6.  An evaluation of the effect of vincristine added to cyclophosphamide, 5-fluorouracil, methotrexate, and prednisone in advanced breast cancer.

Authors:  A Segaloff; B F Hankey; A C Carter; G C Escher; F J Ansfield; R W Talley
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

7.  In vivo protection by protein A of hepatic microsomal mixed function oxygenase system of cyclophosphamide-treated rats.

Authors:  M Dohadwala; P K Ray
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 8.  Mammary cancers and pregnancy.

Authors:  J M Anderson
Journal:  Br Med J       Date:  1979-04-28

Review 9.  Update on cancer chemotherapy: general considerations and breast cancer. Part II.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1985-09       Impact factor: 1.798

10.  The effects of multiple combination chemotherapy with vincristine, cyclophosphamide (Endoxan), methotrexate, 5-fluorouracil, adriamycin and prednisolone (VEMFAH) for advanced breast cancer.

Authors:  T Kojima; A Hoshino; K Ohara; O Kamiya; K Nagata; Y Ito; T Kinoshita; I Sugiura; M Yamada; H Sato
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.